Friday, January 24, 2014 3:34:01 PM
Attorneys, regulatory staff and compliance personnel who work with manufacturers of controlled substances
Regulatory affairs professionals and scientists who work in the area of controlled substances
Pharmacists, medical professionals, public health and consumer advocates, and other individuals working with controlled substances
Academics and other research organizations and members of the press who study and/or report on issues related to controlled substances
This one-day conference focuses on significant developments in FDA and DEA’s regulation of controlled substances. The program brings together government, industry and public health experts to provide updates on the latest regulations, litigation, and enforcement actions affecting controlled substances’ stakeholders. Experts will review key developments in 2013 and discuss what to expect in 2014. A roundtable discussion will address recent scheduling decisions and their practical and policy impacts. Panelists will dialogue with attendees on current issues, including the regulation of marijuana and suspicious order monitoring.
Attendees at our Controlled Substances Conferences included representatives from the following companies:
Arnold & Porter LLP
Cadwalader, Wickersham & Taft LLP
Cardinal Health, Inc.
Covidien
Covington & Burling LLP
Department of Justice
Drug Enforcement Administration
Eisai Inc.
Eli Lilly and Company
Endo Pharmaceuticals Inc.
FDA - CDER
FDA - CVM
FDA - OC
FDAImports.com, LLC
Federal Trade Commission
Healthcare Distribution Management Association
Henry Schein, Inc.
Hogan Lovells LLP
Hyman, Phelps & McNamara, P.C.
Jazz Pharmaceuticals, Inc.
Johnson & Johnson
K&L Gates LLP
Kleinfeld, Kaplan & Becker, LLP
Krieg DeVault LLP
Leavitt Partners, LLC
National Association of Chain Drug Stores
Noramco, Inc.
North Carolina Board of Pharmacy
Otsuka America Pharmaceutical, Inc.
Parsons Behle & Latimer
Pfizer, Inc.
Pharma Compliance Group, Inc.
Pharmaceutical Education & Research Institute, Inc. (PERI)
PhRMA
Pinney Associates, Inc.
Prescription Drug Research Center LLC
Purdue Pharma L.P.
PWR
Shire Specialty Pharmaceuticals
State University of NY at Buffalo
The Drug & Chemical Advisory Group, LLC
Trends-in-Medicine
U.S. Pharmacopeia
United BioSource Corporation
University of Maryland School of Pharmacy
http://www.fdli.org/conferences/conference-pages/2014-controlled-substances-conference
PickleJar Unveils Latest Venue Managed Services Innovations in Upcoming Webinar • PKLE • Aug 23, 2024 1:11 PM
Element79 Gold Corp Provides Update on Nevada Portfolio • ELMGF • Aug 23, 2024 8:00 AM
Maybacks Adds Award Winning Show to Its Lineup Discusses Maybacks Opportunity • AHRO • Aug 22, 2024 11:30 AM
North Bay Resources Announces First Gold Concentrate at Mt. Vernon Gold Mine, Assays 12 oz/ton Gold, 17.5 oz/ton Platinum, and 8 oz./ton Silver, Sierra County, California • NBRI • Aug 22, 2024 10:28 AM
All Things Mobile Analytic, Inc. Reports Major Growth with Over $11 Million in Revenue • ATMH • Aug 22, 2024 7:19 AM
Unitronix Announces Strategic Entry into Cryptocurrency Space • UTRX • Aug 21, 2024 10:00 AM